The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Recurrent/metastatic salivary gland malignancies (RMSGM): Final report of 60 cases treated with cisplatin plus vinorelbine (DDP+VNB).
Fulvia Pedani
No relevant relationships to disclose
Mario Airoldi
No relevant relationships to disclose
Massimiliano Garzaro
No relevant relationships to disclose
Luca Raimondo
No relevant relationships to disclose
Simona Carnio
No relevant relationships to disclose
Gianluca Fora
No relevant relationships to disclose
Carlo Giordano
No relevant relationships to disclose
Giancarlo Pecorari
No relevant relationships to disclose